Physicians of any specialty encounter the chronic course of yersiniasis, the clinical manifestations of which are polymorphic and similar to the symptoms of other diseases, including autoimmune ones. The long interval of an evolving pathological condition after the acute period of the disease leads to the fact that the clinical and laboratory manifestations of chronic yersiniasis are wrongly regarded as an independent nosological entities unassociated with the persistence of Yersinia. Dynamic blood tests for specific IgA to the Yersinia enterocolitica virulence factors that are an indirect sign of on-going pathogen persistence in the body are required to elaborate the tactics for the examination, treatment, and follow-up of patients.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Human genetic variation reveals FCRL3 is a lymphocyte receptor for .
bioRxiv
December 2024
Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA.
is the gram-negative bacterium responsible for plague, one of the deadliest and most feared diseases in human history. This bacterium is known to infect phagocytic cells, such as dendritic cells and macrophages, but interactions with non-phagocytic cells of the adaptive immune system are frequently overlooked despite the importance they likely hold for human infection. To discover human genetic determinants of infection, we utilized nearly a thousand genetically diverse lymphoblastoid cell lines in a cellular genome-wide association study method called Hi-HOST (High-throughput Human in-vitrO Susceptibility Testing).
View Article and Find Full Text PDFType III Secretion System in Intestinal Pathogens and Metabolic Diseases.
J Diabetes Res
November 2024
Department of General Practice, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou 510900, China.
Modern lifestyle changes, especially the consumption of a diet high in salt, sugar, and fat, have contributed to the increasing incidence and prevalence of chronic metabolic diseases such as diabetes, obesity, and gout. Changing lifestyles continuously shape the gut microbiota which is closely related to the occurrence and development of metabolic diseases due to its specificity of composition and structural diversity. A large number of pathogenic bacteria such as , , , and pathogenic in the gut utilize the type III secretion system (T3SS) to help them resist host defenses and cause disease.
View Article and Find Full Text PDFIs the identification of caseating granuloma in the intestine indicative of tuberculosis? a rare case of Crohn's disease.
Diagn Pathol
October 2024
Department of Pathology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Article Synopsis
- Crohn's disease (CD) is a chronic inflammatory condition of the intestines with symptoms like abdominal pain and diarrhea, and granulomas are the most recognized indicator for diagnosing it, though their detection can vary significantly.
- A case study of a 28-year-old woman with CD revealed both caseating and non-caseating granulomas, which improved with treatment.
- The findings suggest that caseous granulomas shouldn't rule out CD as a diagnosis, even in the absence of other conditions like tuberculosis, highlighting the complexity of diagnosing this disease.
Of rats and children: plague, malaria, and the early history of disease reservoirs (1898-1930).
Hist Philos Life Sci
October 2024
University College London, London, UK.
This article's jumping-off point is the highly incisive but often-ignored claim by the French doctor, Louis-Jacques Tanon, in 1922 that rats acted as plague reservoirs in Paris; in other words, that they harboured the plague bacillus but were refractory to it. This claim partially reframed the fight against this disease in the French capital in the 1920s, which became more centred on surveilling the plague reservoir rather than on destroying rats. Drawing upon Tanon's hypothesis, this article explores the emergence, evolution, and several iterations of the idea of disease reservoirs in the early twentieth century.
View Article and Find Full Text PDFInhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery.
J Aerosol Med Pulm Drug Deliv
August 2024
Departments of Pediatrics and Internal Medicine, Lung and Heart-Lung Transplant Programs, The Ohio State University College of Medicine, Columbus, Ohio, USA.
An increasing growth in nanotechnology is evident from the growing number of products approved in the past decade. Nanotechnology can be used in the effective treatment of several pulmonary diseases by developing therapies that are delivered in a targeted manner to select lung regions based on the disease state. Acute or chronic pulmonary disorders can benefit from this type of therapy, including respiratory distress syndrome (RDS), chronic obstructive pulmonary disease (COPD), asthma, pulmonary infections (e.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!